Patents (1339 Stem Cell Patents)

Class: Expansion (401)

Order by:
<< | < | 35 36 37 38 39 40 41 | > | >>


Method for the stimulation of bone marrow cells

Patent Number: 4946437

This patent is a novel way to expand bone marrow cells ex vivo through contacting the bone marrow with a family of compounds. The single issued independent claim covers "A method for the transplantation of bone marrow cells" and the method involved contacting with a specific family of compounds. The first dependent claim states one member of this family of compounds as being...

Inventors: Sredni, Benjamin (Beni Brak, IL); Albeck, Michael (Ramat Gan, IL)
Assignee: Bar-Ilan University (Ramat-Gan, IL)
Date of First Priority Issue: Friday February 12th, 1988

Stimulation of stem cell growth by the bryostatins

Patent Number: 5358711

Bryostatin is a drug derived from a type of symbiont bacteria. Although bryostatin has been used in clinical trials for oncology, results have not been excellent. This patent teaches that bryostatin and various derivatives thereof are useful for stimulation of hematopoietic stem cell proliferation. It will be interesting to see if bryostatin works on stimulating stem cell activity of...

Inventors: May, W. Stratford (Baltimore, MD); Sensenbrenner, Lyle L. (Grosse Pointe Park, MI)
Assignee: Johns Hopkins University (Baltimore, MD)
Date of First Priority Issue: Monday November 23rd, 1987

Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis

Patent Number: 7,307,166

This patent covers the composition of matter for several compounds and family of compounds that increase hematopoiesis. The compounds which are oxpurine nucleosides and their congeners, and acyl derivatives are demonstrated to accelerate hematopoietic reconstitution in both chemotherapy and irradiation induced suppression mouse models. In total the patent has over 70 examples. The...

Inventors: von Borstel; Reid W. (Potomac, MD), Bamat; Michael K. (Potomac, MD), Hiltbrand; Bradley M. (Columbia, MD), Butler; James C. (Gaithersburg, MD), Shirali; Shyam (Gaithersburg, MD)
Assignee: Wellstat Therapeutics Corporation (Gaithersburg, MD)
Date of First Priority Issue: Wednesday October 28th, 1987

Method for enhancing hematopoiesis with acyl deoxyribonucleosides

Patent Number: 6103701

Small molecules are provided that stimulate hematopoietic stem cell proliferation. These molecules may be of interest for stimulation of non-hematopoietic stem cells.

Inventors: von Borstel, Reid Warren (Darnestown, MD); Bamat, Michael Kevin (Darnestown, MD)
Assignee: not stated
Date of First Priority Issue: Wednesday October 28th, 1987

Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors

Patent Number: 6156301

This patent teaches the use of IL-7 for stimulation of hematopoiesis, as well as increasing the output of lymphocytes. IL-7 has several interesting properties, including the ability to support homeostatic expansion of T cells.

Inventors: Namen, Anthony E. (Seattle, WA); Goodwin, Raymond G. (Seattle, WA); Lupton, Stephen D. (Seattle, WA); Mochizuki, Diane Y. (Seattle, WA)
Assignee: Sanofi-Synthelabo (Paris, FR)
Date of First Priority Issue: Monday October 26th, 1987

Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors

Patent Number: 5705149

This patent covers the use of IL-7 to stimulate hematopoiesis.

Inventors: Namen, Anthony E. (Seattle, WA); Goodwin, Raymond G. (Seattle, WA); Lupton, Stephen D. (Seattle, WA); Mochizuki, Diane Y. (Seattle, WA)
Assignee: Sterling Winthrop Inc. (New York, NY)
Date of First Priority Issue: Monday October 26th, 1987

Cellular enhancer for expressing genes in undifferentiated stem cells

Patent Number: 4959313

This patent covers a specific DNA enhancer sequence that is activated uniquely in embryonic stem cells. Such an enhancer is useful for numerous genetic engineering techniques, as well as, I believe, for generation of transgenic animals.

Inventor: Taketo, Makoto (Bar Harbor, ME)
Assignee: The Jackson Laboratory (Bar Harbor, ME)
Date of First Priority Issue: Monday June 22nd, 1987

Polypeptide derivatives of human granulocyte colony stimulating factor

Patent Number: 5362853

G-CSF is used clinically for stimulation of neutrophil production in pateints that have taken chemotherapy, radiation therapy (in some cases), as well as post bone marrow tranplant. This patent covers peptide derivatives of G-CSF that are useful for stimulation of hematopoiesis. It may be interesting to use this patent to compete with currently used G-CSF formulations.

Inventors: Kuga, Tetsuro (Yamaguchi, JP); Miyaji, Hiromasa (Tokyo, JP); Sato, Moriyuki (Tokyo, JP); Okabe, Masami (Shizuoka, JP); Morimoto, Makoto (Shizuoka, JP); Itoh, Seiga (Kanagawa, JP); Yamasaki, Motoo (Tokyo, JP); Yokoo, Yoshiharu (Kanagawa, JP); Yamaguchi, Ka
Assignee: Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)
Date of First Priority Issue: Tuesday December 23rd, 1986

Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses

Patent Number: 5114926

This invention covers the synthethized form of a tetrapeptide that inhibits bone marrow stem cell entery into cell cycle. The original inhibitory activity was derived from fetal calf bone marrow as a biological "soup" but in this patent synthesis and structure are revealed. The use of agents that inhibit stem cell entry into cell cycle could occur when chemotherapy or radiation is...

Inventors: Frindel, Emilia (Paris, FR); Lenfant, Maryse (Gif Sur Yvette, FR); Guigon, Martine (Neuilly, FR); Bakala, Johanna (Paris, FR)
Assignee: Institut National De La Sante Et De La Recherche Medicale (Paris, FR) Institut Gustave Roussy (Paris, FR)
Date of First Priority Issue: Friday July 18th, 1986

Process for replicating bone marrow in vitro and using the same

Patent Number: 4721096

This patent is broad reaching in that it covers the ex vivo expansion of bone marrow for treating a pateint whose bone marrow has been comprised. Essentially, this patent was ahead of its time since numerous companies are trying to perform this process even today. Essentially the patent's since independent claim covers extraction of bone marrow, ex vivo replication so that hematopoietic...

Inventors: Naughton, Brian A. (Yorktown Heights, NY); Naughton, Gail K. (Yorktown Heights, NY)
Assignee: Marrow-Tech Incorporated (Albany, NY)
Date of First Priority Issue: Friday April 18th, 1986

Order by:
<< | < | 35 36 37 38 39 40 41 | > | >>




Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03